Acute and Chronic Kidney Dysfunction and Prognosis following Thrombectomy for Ischemic Stroke
American Journal of Nephrology · 2024
DOI: 10.1159/000536493 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift American Journal of Nephrology, 2024. Verfasst von Mickaël Bobot und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, AP-HM, Marseille, France. Hauptthemen laut MEDLINE: Thrombectomy, Ischemic Stroke, Renal Insufficiency, Chronic, Acute Kidney Injury. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Themen: Schlaganfall
Abstract (Originalsprache)
Introduction
Patients with chronic kidney disease (CKD) have an increased risk of stroke, and CKD seems associated with worse outcome after a stroke. The main objective of our study RISOTTO was to evaluate the influence of CKD and acute kidney injury (AKI) on the clinical outcome and mortality of ischemic stroke patients after thrombolysis and/or thrombectomy.
Methods
This multicenter cohort study included patients in the acute phase of ischemic stroke due to large artery occlusion managed by thrombectomy. Functional outcome at 3 months was assessed by the modified Rankin Scale (mRS).
Results
280 patients were included in the analysis. Fifty-nine patients (22.6%) had CKD. At 3 months, CKD was associated with similar functional prognosis (mRS 3–6: 50.0% vs. 41.7%, p = 0.262) but higher mortality (24.2% versus 9.5%, p = 0.004). In univariate analysis, patients with CKD had a higher burden of white matter hyperintensities (Fazekas score: 1.7 ± 0.8 vs. 1.0 ± 0.8, p = 0.002), lower initial infarct volume with equivalent severity, and lower recanalization success (86.4% vs. 97.0%, p = 0.008) compared to non-CKD patients. Forty-seven patients (20.0%) developed AKI. AKI was associated with poorer 3-month functional outcome (mRS 3–6: 63.8% vs. 49.0%, p = 0.002) and mortality (23.4% versus 7.7%, p = 0.002). In multivariate analysis, AKI appeared as an independent risk factor for poor functional outcome (mRS 3–6: adjOR 2.79 [1.11–7.02], p = 0.029) and mortality (adjOR 2.52 [1.03–6.18], p = 0.043) at 3 months, while CKD was not independently associated with 3-month mortality and poor neurological outcome.
Conclusions
AKI is independently associated with poorer functional outcome and increased mortality at 3 months. CKD was not an independent risk factor for 3-month mortality or poor functional prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre de Néphrologie et Transplantation Rénale, Hôpital de la Conception, AP-HM, Marseille, France.
- Aix Marseille Univ, INSERM, INRAE, C2VN, Marseille, France.
- CERIMED, Aix Marseille Univ, Marseille, France.
- Neuroradiology Department, CHU Timone, AP-HM, Marseille, France.
- LIIE, CERIMED, Aix-Marseille Université, Marseille, France.
- Stroke Unit, UR2CA-URRIS Neurology, Nice Cote d'Azur University, Nice, France.
Zitieren
APA
Bobot, M., Hak, J. F., Casolla, B., Dehondt, J. D., Burtey, S., Doche, E., & Suissa, L. (2024). Acute and Chronic Kidney Dysfunction and Prognosis following Thrombectomy for Ischemic Stroke. American Journal of Nephrology. https://doi.org/10.1159/000536493
Vancouver
Bobot M, Hak JF, Casolla B, Dehondt JD, Burtey S, Doche E, et al. Acute and Chronic Kidney Dysfunction and Prognosis following Thrombectomy for Ischemic Stroke. American Journal of Nephrology. 2024. doi:10.1159/000536493
BibTeX
@article{Bobot2024,
author = {Bobot, Mickaël and Hak, Jean-François and Casolla, Barbara and Dehondt, Jean-Daniel and Burtey, Stéphane and Doche, Emilie and Suissa, Laurent},
title = {Acute and Chronic Kidney Dysfunction and Prognosis following Thrombectomy for Ischemic Stroke},
journal = {American Journal of Nephrology},
year = {2024},
doi = {10.1159/000536493}
}
EUVIMED